ARTICLE | Clinical News
Avexa, Shire preclinical data
December 10, 2007 8:00 AM UTC
In vitro, apricitabine had antiviral activity against HIV strains resistant to integrase inhibitors, including Isentress raltegravir from Merck & Co. Inc. (MRK, Whitehouse Station, N.J.). AVX has wo...